Zydus Lifesciences gets FDA tentative approval for Invokamet generic

Pallavi Madhiraju- February 22, 2023 0

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin Hydrochloride Tablets, 50mg/500mg, 50mg/1,000mg, 150mg/500mg, and 150mg/1,000mg ... Read More

Zydus Lifesciences gets FDA tentative approval for Gabapentin Tablets

Pallavi Madhiraju- February 20, 2023 0

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for once-daily Gabapentin Tablets, 300 mg and 600 mg from the US ... Read More

Zydus Lifesciences subsidiary launches Trokendi XR generic in US

Pallavi Madhiraju- January 8, 2023 0

Zydus Lifesciences (previously Cadila Healthcare) said that its subsidiary Zydus Pharmaceuticals (USA) Inc. has launched Topiramate Extended-Release Capsules in the US. The launch follows the ... Read More

Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

Pallavi Madhiraju- November 28, 2022 0

Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, ... Read More

Zydus Lifesciences gets FDA final approval for Brivaracetam generic

Pallavi Madhiraju- October 6, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has bagged final approval to market Brivaracetam Tablets USP 10 mg, 25 ... Read More

Zydus Lifesciences gets final FDA approval for Mirabegron generic

Pallavi Madhiraju- October 4, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More

Zydus Lifesciences gets tentative FDA approval for Sugammadex generic

pallavi123- September 18, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 ... Read More

Zydus Lifesciences bags FDA approval for Cariprazine generic

pallavi123- September 17, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration ... Read More

Zydus gets FDA approval for COPD drug Roflumilast Tablets

pallavi123- February 14, 2022 0

Zydus Group said that its subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) to market Roflumilast Tablets ... Read More

Zydus Cadila gets FDA tentative approval for Cariprazine Capsules

pallavi123- December 12, 2021 0

Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval from the US Food and Drug Administration (FDA) to commercialize Cariprazine Capsules ... Read More